Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)

NCT00839436 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

21

Enrollment

NIH

Sponsor class

Stopped Bankruptcy of Drug manufacturer: Drug not available

Conditions

Idiopathic CD4+ T-Lymphocytopenia

Interventions

DRUG: CYT107

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)